Gene · 211
Papers1,411
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,411
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CLPP-Null Eukaryotes with Excess Heme Biosynthesis Show Reduced L-arginine Levels, Probably via CLPX-Mediated OAT Activation. | Biomolecules | 2024 | 38397478 | PubTator, text mining | PubMed |
| Folate depletion induces erythroid differentiation through perturbation of de novo purine synthesis. | Sci Adv | 2024 | 38295180 | PubTator, text mining | PubMed |
| Transcriptome and machine learning analysis of the impact of COVID-19 on mitochondria and multiorgan damage. | PLoS One | 2024 | 38295140 | PubTator, text mining | PubMed |
| Low expression of PRRG2 in kidney renal clear cell carcinoma: an immune infiltration-associated prognostic biomarker. | Discov Oncol | 2024 | 38227081 | PubTator, text mining | PubMed |
| Pathway crosstalk between the central metabolic and heme biosynthetic pathways in Phanerochaete chrysosporium. | Appl Microbiol Biotechnol | 2024 | 38183476 | PubTator, text mining | PubMed |
| Reprogramming and multi-lineage transdifferentiation attenuate the tumorigenicity of colorectal cancer cells. | J Biol Chem | 2024 | 38072050 | PubTator, text mining | PubMed |
| Epstein-Barr virus induces germinal center light zone chromatin architecture and promotes survival through enhancer looping at the BCL2A1 locus. | mBio | 2024 | 38059622 | PubTator, text mining | PubMed |
| Integration of single-cell and bulk RNA-sequencing to analyze the heterogeneity of hepatocellular carcinoma and establish a prognostic model. | Cancer Rep (Hoboken) | 2024 | 37994394 | PubTator, text mining | PubMed |
| Estrogen receptor α interaction of zearalenone and its phase I metabolite α-zearalenol in combination with soy isoflavones in hERα-HeLa-9903 cells. | Mycotoxin Res | 2024 | 37847468 | PubTator, text mining | PubMed |
| A case report of acute intermittent porphyria leading to severe disability. | Front Neurol | 2023 | 38274883 | PubTator, text mining | PubMed |
| Cimetidine Does Not Inhibit 5-Aminolevulinic Acid Synthase or Heme Oxygenase Activity: Implications for Treatment of Acute Intermittent Porphyria and Erythropoietic Protoporphyria. | Biomolecules | 2023 | 38254627 | PubTator, text mining | PubMed |
| TGF-β-regulated different iron metabolism processes in the development and cisplatin resistance of ovarian cancer. | Oncol Res | 2023 | 38186569 | PubTator, text mining | PubMed |
| Hepatocyte-targeted siTAZ therapy lowers liver fibrosis in NASH diet-fed chimeric mice with hepatocyte-humanized livers. | Mol Ther Methods Clin Dev | 2023 | 38144682 | PubTator, text mining | PubMed |
| Recent progress in the role of endogenous metal ions in doxorubicin-induced cardiotoxicity. | Front Pharmacol | 2023 | 38143497 | PubTator, text mining | PubMed |
| RNA Combined with Nanoformulation to Advance Therapeutic Technologies. | Pharmaceuticals (Basel) | 2023 | 38139761 | PubTator, text mining | PubMed |
| Traffic Density Exposure, Oxidative Stress Biomarkers and Plasma Metabolomics in a Population-Based Sample: The Hortega Study. | Antioxidants (Basel) | 2023 | 38136241 | PubTator, text mining | PubMed |
| The diagnosis of acute intermittent porphyria combined with seizures: Case report. | Medicine (Baltimore) | 2023 | 38115298 | PubTator, text mining | PubMed |
| A resource of induced pluripotent stem cell (iPSC) lines including clinical, genomic, and cellular data from genetically isolated families with mood and psychotic disorders. | Transl Psychiatry | 2023 | 38104115 | PubTator, text mining | PubMed |
| APOBEC3G Is a p53-Dependent Restriction Factor in Respiratory Syncytial Virus Infection of Human Cells Included in the p53/Immune Axis. | Int J Mol Sci | 2023 | 38069117 | PubTator, text mining | PubMed |
| Integrated omics analysis of coronary artery calcifications and myocardial infarction: the Framingham Heart Study. | Sci Rep | 2023 | 38062110 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/211/papers?page=4